Skip to content

The Impact of Long-term Pessary Use on Pelvic Organ Prolapse oìduring Covid-19 Pandemic in Patients Attending Surgery

The Impact of Long-term Pessary Use on Pelvic Organ Prolapse oìduring Covid-19 Pandemic in Patients Attending Surgery

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06234449
Enrollment
200
Registered
2024-01-31
Start date
2024-07-31
Completion date
2026-03-31
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse, Vaginal Prolapse

Brief summary

Patients aged 45 to 80 years with a clinical diagnosis of stage III and IV genital prolapse involving the anterior and/or middle compartments and candidates for surgery will be considered. These will be evaluated to observe whether there is improvement in clinical prolapse with the use of the vaginal pessary during the waiting period for surgery

Interventions

PROCEDUREVaginal pessary before surgery for pelvic organ prolapse

use of vaginal pessary for patients waiting for gynecological surgery for stage III and IV pelvic organ prolapse

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pelvic organ prolapse with POP-Q stage \>/= 3 in anterior and/or central compartments * Women between 45 and 80 years old

Exclusion criteria

* Women who refuse to participate in the study * Patients without baseline POPQ examination documented or with a pessary previously positioned * Previous pelvic surgeries * Women with any contraindication for surgery or preference for conservative treatment only (pelvic muscle exercise, vaginal pessary) * Women who are not successfully fitted with pessaries * Current genital ulcers/infections * Active or chronic pelvic infection * Women who are mentally incapable of completing the questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
evaluate a change in POPQ points on examination at the time of surgery from baseline evaluation.At the time of surgery procedure, after at least 6 months after pessary placementPrimary endopoint is the evaluation of the percentage of women who experience a change in any POPQ point on examination at the time of surgery from baseline evaluation.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026